🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Goal of this study is to investigate if individuals ages 12 years and o...
Status
Active Not Recruiting
Location
Boston Children's Hospital
Start Date
2021-09-08
Trial ID
NCT03694158
This study is researching a drug called dupilumab. The study is focused on ...
Status
Active Not Recruiting
Location
Kern Research, Inc
Start Date
2024-08-26
Trial ID
NCT06572228
Treatments Being Tested
The main objective of the trial is to evaluate the efficacy of 2 dose regim...
Status
Completed
Location
Site 1
Start Date
2016-01-31
Trial ID
NCT02755649
Treatments Being Tested
The main objective of the trial is to demonstrate the efficacy of dupilumab...
Status
Completed
Location
Regeneron Research Site
Start Date
2017-11-17
Trial ID
NCT03345914
The primary objective of the study is to assess the clinical efficacy of re...
Status
Completed
Location
Multiple Locations
Start Date
2015-05-12
Trial ID
NCT02379052
The main purpose of this study is to investigate whether dupilumab is effec...
Status
Completed
Location
Regeneron study Site
Start Date
2020-10-28
Trial ID
NCT04206553
Treatments Being Tested
This study is researching a drug called dupilumab, referred to as "study dr...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-30
Trial ID
NCT07587658
Primary Objective: To evaluate the efficacy of dupilumab (SAR231893/REGN66...
Status
Completed
Location
Investigational Site Number 840014
Start Date
2013-08
Trial ID
NCT01920893
Treatments Being Tested
This is a randomized, double-blind, placebo-controlled, parallel-group stud...
Status
Completed
Location
Multiple Locations
Start Date
2014-11-30
Trial ID
NCT02277769
Treatments Being Tested
The goal of this observational study is to comprehensively profile six immu...
Status
Recruiting
Location
Radboud University Medical Center
Start Date
2025-07-29
Trial ID
NCT07021495